PN
Pinnenti Nageswara Rao
About Pinnenti Nageswara Rao
Data last updated:
Pinnenti Nageswara Rao is a Managing Director at Svr Drugs Private Limited (since 2010), Additional Director at Bhasya International Private Limited (since 2025) and Managing Director at S.V.R. Laboratories Private Limited (since 2008), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹239 Cr; the largest is Svr Drugs Private Limited at ₹131 Cr (FY 2025). Earlier, Pinnenti Nageswara Rao was a Director at Venlar Labs Private Limited (2002–2022) and Director at Progenerics Pharma Private Limited (2015–2017) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Svr Drugs Private Limited U24232AP2010PTC070173 | Managing Director | 29 Nov 2010 | 2010 | ₹131 Cr (FY 2025) | Active |
 Bhasya International Private Limited U51909TG2020PTC142949 | Additional Director | 18 Aug 2025 | 2020 | ₹59.51 Cr (FY 2024) | Active |
| S.V.R. Laboratories Private Limited U24239TG2003PTC041653 | Managing Director | 10 Mar 2008 | 2003 | ₹44.45 Cr (FY 2025) | Active |
| Srinag Pharma Private Limited U24299TG2017PTC119111 | Director | 25 Aug 2017 | 2017 | ₹4.43 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Venlar Labs Private Limited U24239TG2002PTC038746 | Director | 04 Apr 2002 | 2002 | Active | |
 Progenerics Pharma Private Limited U24233TG2015PTC102075 | Director | 05 Dec 2015 | 2015 | ₹2.96 Cr (FY 2025) | Active |
 Venkar Chemicals Private Limited U24110TG1999PTC031012 | Director | 05 Sep 2007 | 1999 | ₹113 Cr (FY 2024) | Active |
| Satyadeva Pharmaceuticals Private Limited U24239TG2000PTC035107 | Director | 03 Oct 2003 | 2000 | ₹103 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pinnenti Nageswara Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nagadurga Pinneti | 05266166 | Svr Drugs Private Limited , S.V.R. Laboratories Private Limited | Whole-Time Director |
| Srinivasulu Chowdary Kavuturu | 00030543 | Svr Drugs Private Limited , S.V.R. Laboratories Private Limited and 1 more | Director |
| Srivani Kavuturu | 07904722 | Svr Drugs Private Limited , S.V.R. Laboratories Private Limited | Director |
| Bhaskara Rao Akkapolu | 10408382 | Bhasya International Private Limited , Srinag Pharma Private Limited | Director |
| Jaya Sai Yarlagadda | 08838984 | Bhasya International Private Limited | Director |
| Sravani Koratana | 08838985 | Bhasya International Private Limited | Director |
| Syam Kumar Kokku | 10408361 | Bhasya International Private Limited , Srinag Pharma Private Limited | Additional Director |
| Veera Basava Shivakumari Samatham | 10416024 | Bhasya International Private Limited , Srinag Pharma Private Limited | Additional Director |
| Manoj Sai Pinnenti | 09704811 | S.V.R. Laboratories Private Limited , Srinag Pharma Private Limited | Director |
| Kavuturu Harshavardhan | 08721115 | Srinag Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pinnenti Nageswara Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pinnenti Nageswara Rao
Pinnenti Nageswara Rao currently holds 4 directorships: Svr Drugs Private Limited (Managing Director, since 29 Nov 2010, revenue ₹131 Cr (FY 2025)); Bhasya International Private Limited (Additional Director, since 18 Aug 2025, revenue ₹59.51 Cr (FY 2024)); S.V.R. Laboratories Private Limited (Managing Director, since 10 Mar 2008, revenue ₹44.45 Cr (FY 2025)); Srinag Pharma Private Limited (Director, since 25 Aug 2017, revenue ₹4.43 Cr (FY 2024)).
Pinnenti Nageswara Rao was first appointed on 04 Apr 2002 as Director at Venlar Labs Private Limited. The most recent appointment on record is 18 Aug 2025 at Bhasya International Private Limited.
The 4 current companies of Pinnenti Nageswara Rao that report revenue have a combined latest revenue of ₹239 Cr: Svr Drugs Private Limited ₹131 Cr (FY 2025); Bhasya International Private Limited ₹59.51 Cr (FY 2024); S.V.R. Laboratories Private Limited ₹44.45 Cr (FY 2025); Srinag Pharma Private Limited ₹4.43 Cr (FY 2024).
Pinnenti Nageswara Rao held 4 earlier board appointments: Venlar Labs Private Limited (Director, 04 Apr 2002 to 20 Apr 2022); Progenerics Pharma Private Limited (Director, 05 Dec 2015 to 04 Sep 2017); Venkar Chemicals Private Limited (Director, 05 Sep 2007 to 05 Oct 2018); Satyadeva Pharmaceuticals Private Limited (Director, 03 Oct 2003 to 11 Sep 2012).
The current boards of Pinnenti Nageswara Rao's companies include Nagadurga Pinneti (Svr Drugs Private Limited), Srinivasulu Chowdary Kavuturu (Svr Drugs Private Limited), Srivani Kavuturu (Svr Drugs Private Limited), Bhaskara Rao Akkapolu (Bhasya International Private Limited), Jaya Sai Yarlagadda (Bhasya International Private Limited), Sravani Koratana (Bhasya International Private Limited), among others.